Item 15. Exhibits and Financial Statement Schedules

**1.**Financial Statements

The following consolidated financial statements of the Company are submitted herewith:

Management’s Annual Report on Internal Control Over Financial Reporting

Report of Independent Registered Public Accounting Firm – KPMG LLP

Report of Independent Registered Public Accounting Firm – KPMG LLP

Consolidated Balance Sheets – February 28, 2025, and February 29, 2024

Consolidated Statements of Comprehensive Income (Loss) for the years ended February 28, 2025, February 29, 2024, and February 28, 2023

Consolidated Statements of Changes in Stockholders’ Equity for the years ended February 28, 2025, February 29, 2024, and February 28, 2023

Consolidated Statements of Cash Flows for the years ended February 28, 2025, February 29, 2024, and February 28, 2023

Notes to Consolidated Financial Statements

**2.**Financial Statement Schedules

Schedules are not submitted because they are not applicable or not required under Regulation S-X or because the required information is included in the financial statements or notes thereto.

**3.**Exhibits required to be filed by Item 601 of Regulations S-K

The information called for by this Item is incorporated by reference from the Index to Exhibits included in this Form 10-K.